我国《药品差比价规则(试行)》分析  

Analysis of the "Regulation of Drug Price Difference (Trial Implementation)" in China

作　　者：朱明蕾[1] 史录文[1] 

机构地区：[1]北京大学药学院药事管理和临床药学系,北京市100088

出　　处：《中国药房》2009年第28期2165-2167,共3页China Pharmacy

摘　　要：目的:为进一步完善国家发改委《药品差比价规则(试行)》(下简称《规则》)提供参考。方法:回顾我国药品价格管理历程,以北京市12家医院为例分析《规则》实施后取得的成效及局限,提出完善建议。结果与结论:《规则》在药品定价管理方面形成了较为统一规范的评价标准、计算方法,乃至整体的评价体系,降低了药品价格管理中的人为因素影响和行政管理成本,提高了政府定价效率,但仍需不断完善其中不合理的差比价系数和计算方法。OBJECTIVE： To provide reference for perfecting the ＂Regulation of Drug Price Difference＂ issued by National Development and Reform Commission. METHODS： To review the drug price management course in China, analyze the effects and limitations since the initiation of ＂Regulation of Drug Price Difference＂ in 12 hospitals in Beijing and put forward sugges- tions for its improvement. RESULTS ＆ CONCLUSIONS： ＂Regulation of Drug Price Difference＂ has contributed to the for- mation of unified and standard evaluation criterion and computation method or even the holistic evaluation system in drug pricing management, the lowering of the costs of human factors and administrative management in drug price management and the improvement of the governmental pricing efficiency. However, efforts should be taken to improve the unreasonable drug price difference coefficient and computation method and so on.

关 键 词：药品 价格管理 差比价规则 

分 类 号：R951[医药卫生—药学]